LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $973,965 | +180.5% | 14,500 | +101.4% | 0.01% | +166.7% |
| Q1 2023 | $347,184 | -49.6% | 7,200 | -47.8% | 0.00% | -50.0% |
| Q4 2022 | $688,896 | -17.6% | 13,800 | -32.7% | 0.01% | -14.3% |
| Q3 2022 | $836,000 | -80.4% | 20,500 | -73.6% | 0.01% | -82.9% |
| Q2 2022 | $4,276,000 | +70.7% | 77,732 | +12.8% | 0.04% | +78.3% |
| Q1 2022 | $2,505,000 | -10.4% | 68,934 | +24.6% | 0.02% | -20.7% |
| Q3 2021 | $2,797,000 | +166.6% | 55,303 | +116.3% | 0.03% | +163.6% |
| Q2 2021 | $1,049,000 | – | 25,566 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |